Literature DB >> 23152334

Immunopathogenesis and neurological manifestations associated to HTLV-1 infection.

Anselmo Souza1, Davi Tanajura, Cristina Toledo-Cornell, Silvane Santos, Edgar Marcelino de Carvalho.   

Abstract

The human T lymphotropic virus type-1 (HTLV-1) was the first human retrovirus identified. The virus is transmitted through sexual intercourse, blood transfusion, sharing of contaminated needles or syringes and from mother to child, mainly through breastfeeding. In addition to the well-known association between HTLV-1 and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), several diseases and neurologic manifestations have been associated with the virus. This review was conducted through a PubMed search of the terms HTLV-1, immune response and neurological diseases. Emphasis was given to the most recent data regarding pathogenesis and clinical manifestations of HTLV-1 infection. The aim of the review is to analyze the immune response and the variety of neurological manifestations associated to HTLV-1 infection. A total of 102 articles were reviewed. The literature shows that a large percentage of HTLV-1 infected individuals have others neurological symptoms than HAM/TSP. Increased understanding of these numerous others clinical manifestations associated to the virus than adult T cell leukemia/lymphoma (ATLL) and HAM/TSP has challenged the view that HTLV-1 is a low morbidity infection.

Entities:  

Mesh:

Year:  2012        PMID: 23152334     DOI: 10.1590/s0037-86822012000500002

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  10 in total

1.  Hypometabolism of watershed areas of the brain in HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Akitoshi Taniguchi; Hitoshi Mochizuki; Shigeki Nagamachi; Yuka Ebihara; Nobuyuki Ishii; Kazutaka Shiomi; Masamitsu Nakazato
Journal:  Neurol Sci       Date:  2015-07-09       Impact factor: 3.307

2.  Functional activity of monocytes and macrophages in HTLV-1 infected subjects.

Authors:  Camila F Amorim; Anselmo S Souza; Angela G Diniz; Natália B Carvalho; Silvane B Santos; Edgar M Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2014-12-18

3.  Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients.

Authors:  Rilma F S Santos; Gildásio C Conceição; Márcia S Martins; Angiolina Kraychete; Maria A C Penalva; Edgar M Carvalho; Antonio Alberto Lopes; Paulo Novis Rocha
Journal:  BMC Nephrol       Date:  2017-02-15       Impact factor: 2.388

4.  Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients.

Authors:  Elaine Coutinho Netto; Alfredo Carlos Silva; Célia Pedroso; Carlos Brites
Journal:  Viruses       Date:  2021-11-04       Impact factor: 5.818

5.  Comment: seroprevalence of HTLV-1/2 among blood donors in the state of Maranhão, Brazil.

Authors:  Edgar M Carvalho
Journal:  Rev Bras Hematol Hemoter       Date:  2014

6.  Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.

Authors:  Beatriz Helena B Vasconcelos; Givago S Souza; Tatiana G C P Barroso; Luiz Carlos L Silveira; Rita Catarina M Sousa; Bianca Callegari; Marília B Xavier
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

7.  Spinal cord hypometabolism associated with infection by human T-cell lymphotropic virus type 1(HTLV-1).

Authors:  Luiz C F Romanelli; Débora M Miranda; Anna B F Carneiro-Proietti; Marcelo Mamede; Herika M M Vasconcelos; Marina L Martins; Anísia S D Ferreira; Daniela V F Rosa; Jonas J Paula; Marco A Romano-Silva; Rodrigo Nicolato
Journal:  PLoS Negl Trop Dis       Date:  2018-08-27

8.  Association between serum zinc and copper levels and antioxidant defense in subjects infected with human T-lymphotropic virus type 1.

Authors:  Samaneh Abolbashari; Susan Darroudi; Maryam Tayefi; Zahra Khashyarmaneh; Parvin Zamani; Hamideh Moalemzadeh Haghighi; Amir Hooshang Mohammadpour; Shima Tavalaei; Mahsa Ahmadnezhad; Habibollah Esmaily; Gordon A Ferns; Zahra Meshkat; Majid Ghayour-Mobarhan
Journal:  J Blood Med       Date:  2018-12-27

9.  Onabotulinumtoxin type A improves lower urinary tract symptoms and quality of life in patients with human T cell lymphotropic virus type 1 associated overactive bladder.

Authors:  Jose Abraão Carneiro Neto; Silvane Braga Santos; Gloria Orge Orge; Davi Tanajura; Lucia Passos; Cassius José Oliveira; Rosana Andrade; Cláudio Galeno de Melo; Ubirajara Barroso; Edgar M Carvalho
Journal:  Braz J Infect Dis       Date:  2018-02-17       Impact factor: 3.257

10.  The impact of urinary incontinence on the quality of life and on the sexuality of patients with HAM/TSP.

Authors:  Maria Rita Polo Gascón; Mirella de Almeida Mellão; Sandra Helena Mello; Rosangela Maria Negrão; Jorge Casseb; Augusto César Penalva de Oliveira
Journal:  Braz J Infect Dis       Date:  2018-08-24       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.